Indutrade

Regulatory Filings • Jul 8, 2013

Visitors' address: Raseborgsgatan 9 Phone: + 46 8 703 03 00 E-mail: info@indutrade.se www.indutrade.se

This information is in accordance with the Swedish Securities Market Act, the Swedish Financial Instruments Trading Act and/or the regulations of Nasdaq OMX Stockholm. The information was submitted for publication at 1.15 p.m. on 8 July 2013.

Press release

Indutrade strengthens its position in medical technology

Indutrade today signed an agreement to acquire all of the shares in AMAB, Sweden, with annual sales of approximately SEK 35 million.

AMAB is one of the market's leading suppliers of medical alert systems, monitoring systems and security systems to the healthcare sector.

Possession will be transferred today, and the company will be part of Indutrade's Industrial Components business area. The acquisition is expected to have a marginally positive impact on Indutrade's earnings per share.

Stockholm, 8 July 2013

INDUTRADE AB (publ)

For further information, please contact: Johnny Alvarsson, President and CEO, tel. +46 70 589 17 95.

About Indutrade

Indutrade markets and sells components, systems and services with a high-tech content within selected niches. Indutrade's business is distinguished by

• High-tech products for recurring needs
• Growth through a structured and tried-and tested acquisition strategy
• A decentralised organisation characterised by an entrepreneurial spirit.

The Group is organised into four business areas: Engineering & Equipment, Flow Technology, Industrial Components and Special Products. Indutrade's sales totalled SEK 8,384 million in 2012, generating operating income of SEK 905 million before depreciation of intangible assets. Indutrade is listed on the Nasdaq OMX Stockholm.